Literature DB >> 30298412

Short- vs long-course antibiotic therapy for pneumonia: a comparison of systematic reviews and guidelines for the SIMI Choosing Wisely Campaign.

Ludovico Furlan1, Luca Erba2, Lucia Trombetta2, Roberto Sacco2, Giorgio Colombo2, Giovanni Casazza3, Monica Solbiati4, Nicola Montano5,6, Chiara Marta7, Rodolfo Sbrojavacca8, Francesco Perticone9, Gino Roberto Corazza10, Giorgio Costantino4,5.   

Abstract

Reduction of the inappropriate use of antibiotics in clinical practice is one of the main goals of the Società Italiana di Medicina Interna (SIMI) choosing wisely campaign. We conducted a systematic review of secondary studies (systematic reviews and guidelines) to verify what evidence is available on the duration of antibiotic treatment in Pneumonia. A literature systematic search was performed to identify all systematic reviews and the three most cited and recent guidelines that address the duration of antibiotic therapy in pneumonia. Moreover, a meta-analysis of non-duplicate data from randomized controlled trials (RCTs) considered in the enrolled systematic reviews was performed together with a trial sequential analysis to identify the need for further studies. Two systematic reviews on antibiotic duration in community-acquired pneumonia (CAP) for a total of 17 RCTs (2764 patients) were enrolled in our study. Meta-analysis of non-duplicate RCTs show a non-significant difference in rate of treatment failure between short (≤ 7 days) and long (> 7 days) antibiotic treatment course: RR 1.05 (95% CI, 0.82-1.36). The trial sequential analysis suggests that further data would not affect current evidence or become clinically relevant. Selected guidelines suggest consideration of a short course, with a low grade of evidence and without citing the already published systematic reviews. Antibiotic treatment of CAP for ≤ 7 days is not associated with a higher rate of treatment failure than longer courses and should thus be taken in consideration. Guidelines should upgrade the evidence on this topic.

Entities:  

Keywords:  Antibiotic treatment; Choosing wisely; Guidelines; Infection; Pneumonia; Systematic review

Mesh:

Substances:

Year:  2018        PMID: 30298412     DOI: 10.1007/s11739-018-1955-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  67 in total

1.  Comparison of 7 versus 10 days of antibiotic therapy for hospitalized patients with uncomplicated community-acquired pneumonia: a prospective, randomized, double-blind study.

Authors:  R E Siegel; M Alicea; A Lee; R Blaiklock
Journal:  Am J Ther       Date:  1999-07       Impact factor: 2.688

2.  Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial.

Authors:  A Castro-Guardiola; A L Viejo-Rodríguez; S Soler-Simon; A Armengou-Arxé; V Bisbe-Company; G Peñarroja-Matutano; J Bisbe-Company; F García-Bragado
Journal:  Am J Med       Date:  2001-10-01       Impact factor: 4.965

3.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

4.  Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.

Authors:  Richard Wai Wing Lee; Steven Terence Lindstrom
Journal:  Respirology       Date:  2007-01       Impact factor: 6.424

5.  Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Authors:  Andre C Kalil; Mark L Metersky; Michael Klompas; John Muscedere; Daniel A Sweeney; Lucy B Palmer; Lena M Napolitano; Naomi P O'Grady; John G Bartlett; Jordi Carratalà; Ali A El Solh; Santiago Ewig; Paul D Fey; Thomas M File; Marcos I Restrepo; Jason A Roberts; Grant W Waterer; Peggy Cruse; Shandra L Knight; Jan L Brozek
Journal:  Clin Infect Dis       Date:  2016-07-14       Impact factor: 9.079

6.  Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia.

Authors:  J A Ramirez; S Vargas; G W Ritter; M E Brier; A Wright; S Smith; D Newman; J Burke; M Mushtaq; A Huang
Journal:  Arch Intern Med       Date:  1999-11-08

7.  Evaluation of an algorithm for switching from IV to PO therapy in clinical practice in patients with community-acquired pneumonia.

Authors:  Menno M van der Eerden; Casper S de Graaff; Fer Vlaspolder; Willem Bronsveld; Henk M Jansen; Wim G Boersma
Journal:  Clin Ther       Date:  2004-02       Impact factor: 3.393

8.  Three-day azithromycin compared with ten-day roxithromycin treatment of atypical pneumonia.

Authors:  S Schönwald; B Barsić; I Klinar; M Gunjaca
Journal:  Scand J Infect Dis       Date:  1994

Review 9.  Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.

Authors:  Richard Pugh; Chris Grant; Richard P D Cooke; Ged Dempsey
Journal:  Cochrane Database Syst Rev       Date:  2015-08-24

10.  Vital signs: improving antibiotic use among hospitalized patients.

Authors:  Scott Fridkin; James Baggs; Ryan Fagan; Shelley Magill; Lori A Pollack; Paul Malpiedi; Rachel Slayton; Karim Khader; Michael A Rubin; Makoto Jones; Matthew H Samore; Ghinwa Dumyati; Elizabeth Dodds-Ashley; James Meek; Kimberly Yousey-Hindes; John Jernigan; Nadine Shehab; Rosa Herrera; Clifford L McDonald; Amy Schneider; Arjun Srinivasan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-03-07       Impact factor: 17.586

View more
  2 in total

1.  Shorter versus longer durations of antibiotic treatment for patients with community-acquired pneumonia: a protocol for a systematic review and meta-analysis.

Authors:  Arnav Agarwal; Ya Gao; Luis Enrique Colunga Lozano; Saad Asif; Layla Bakaa; Maryam Ghadimi; John Basmaji; Aninditee Das; Mark Loeb; Gordon Guyatt
Journal:  BMJ Open       Date:  2022-06-24       Impact factor: 3.006

2.  Learning Analytics Applied to Clinical Diagnostic Reasoning Using a Natural Language Processing-Based Virtual Patient Simulator: Case Study.

Authors:  Raffaello Furlan; Mauro Gatti; Roberto Mene; Dana Shiffer; Chiara Marchiori; Alessandro Giaj Levra; Vincenzo Saturnino; Enrico Brunetta; Franca Dipaola
Journal:  JMIR Med Educ       Date:  2022-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.